IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 187 filers reported holding IMMUNOGEN INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,157 | -3.9% | 324,926 | +14.3% | 0.01% | 0.0% |
| Q2 2023 | $5,366 | +478.2% | 284,389 | +17.7% | 0.01% | +600.0% |
| Q1 2023 | $928 | -14.4% | 241,711 | +10.6% | 0.00% | 0.0% |
| Q4 2022 | $1,084 | -99.9% | 218,627 | +5.6% | 0.00% | 0.0% |
| Q3 2022 | $990,000 | +5.9% | 207,030 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $935,000 | -5.3% | 207,766 | +0.2% | 0.00% | 0.0% |
| Q1 2022 | $987,000 | -33.3% | 207,333 | +3.9% | 0.00% | 0.0% |
| Q4 2021 | $1,480,000 | +103.3% | 199,520 | +55.3% | 0.00% | 0.0% |
| Q3 2021 | $728,000 | -31.7% | 128,436 | -20.6% | 0.00% | 0.0% |
| Q2 2021 | $1,066,000 | -17.8% | 161,705 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $1,297,000 | +29.1% | 160,100 | +2.8% | 0.00% | 0.0% |
| Q4 2020 | $1,005,000 | +77.2% | 155,800 | -1.0% | 0.00% | 0.0% |
| Q3 2020 | $567,000 | -21.7% | 157,400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $724,000 | +63.1% | 157,400 | +20.8% | 0.00% | 0.0% |
| Q1 2020 | $444,000 | -33.2% | 130,300 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $665,000 | +95.6% | 130,300 | -7.4% | 0.00% | – |
| Q3 2019 | $340,000 | +11.5% | 140,700 | 0.0% | 0.00% | – |
| Q2 2019 | $305,000 | -19.9% | 140,700 | 0.0% | 0.00% | – |
| Q1 2019 | $381,000 | -43.6% | 140,700 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $675,000 | -50.2% | 140,700 | -1.7% | 0.00% | -50.0% |
| Q3 2018 | $1,356,000 | -2.2% | 143,200 | +0.4% | 0.00% | 0.0% |
| Q2 2018 | $1,387,000 | +24.4% | 142,600 | +34.5% | 0.00% | +100.0% |
| Q1 2018 | $1,115,000 | +106.5% | 106,000 | +25.7% | 0.00% | 0.0% |
| Q4 2017 | $540,000 | -16.3% | 84,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $645,000 | +7.7% | 84,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $599,000 | +83.7% | 84,300 | -0.0% | 0.00% | – |
| Q1 2017 | $326,000 | +89.5% | 84,301 | +0.0% | 0.00% | – |
| Q4 2016 | $172,000 | -23.9% | 84,300 | 0.0% | 0.00% | – |
| Q3 2016 | $226,000 | -13.1% | 84,300 | 0.0% | 0.00% | – |
| Q2 2016 | $260,000 | -63.8% | 84,300 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $718,000 | -37.2% | 84,300 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $1,144,000 | +41.4% | 84,300 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $809,000 | -37.7% | 84,300 | -6.7% | 0.00% | -50.0% |
| Q2 2015 | $1,299,000 | – | 90,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |